200 related articles for article (PubMed ID: 25149881)
1. 50-bp Ins/Del polymorphism of SOD1 is associated with increased risk of cardiovascular disease.
Eskandari-Nasab E; Kharazi-Nejad E; Nakhaee A; Afzali M; Tabatabaei SP; Tirgar-Fakheri K; Hashemi M
Acta Med Iran; 2014; 52(8):591-5. PubMed ID: 25149881
[TBL] [Abstract][Full Text] [Related]
2. 50-bp insertion/deletion polymorphism of the superoxide dismutase-1 is associated with bladder cancer risk in an Iranian population.
Sarabandi S; Effatpanah H; Sereshki N; Samavarchi Tehrani S; Moradi-Sardareh H
Nucleosides Nucleotides Nucleic Acids; 2022; 41(2):154-165. PubMed ID: 34903144
[TBL] [Abstract][Full Text] [Related]
3. Influence of a 50bp Ins/Del polymorphism at promoter of the superoxide dismutase-1 on gene expression and risk of heroin dependency.
Saify K; Saadat M
Environ Health Prev Med; 2017 Mar; 22(1):4. PubMed ID: 29165112
[TBL] [Abstract][Full Text] [Related]
4. A 50-bp Ins/Del polymorphism at the promoter region of the superoxide dismutase-1 and bipolar disorder type 1.
Kordestanian N; Saadat M
Nord J Psychiatry; 2017 Nov; 71(8):570-573. PubMed ID: 28750571
[TBL] [Abstract][Full Text] [Related]
5. The functional 4-bp insertion/deletion ATTG polymorphism in the promoter region of NF-KB1 reduces the risk of BC.
Eskandari-Nasab E; Hashemi M; Ebrahimi M; Amininia S
Cancer Biomark; 2016; 16(1):109-15. PubMed ID: 26835711
[TBL] [Abstract][Full Text] [Related]
6. 50 bp deletion in promoter superoxide dismutase 1 gene and increasing risk of cardiovascular disease in Mashhad stroke and heart atherosclerotic disorder cohort study.
Darroudi S; Tajbakhsh A; Esmaily H; Ghazizadeh H; Zamani P; Sadabadi F; Tayefi M; Tayefi B; Fereydouni N; Mouhebati M; Akbari Sark N; Avan A; Ferns GA; Mohammadpour AH; Asadi Z; Ghayour-Mobarhan M
Biofactors; 2020 Jan; 46(1):55-63. PubMed ID: 31670860
[TBL] [Abstract][Full Text] [Related]
7. The rs2234694 and 50 bp Insertion/Deletion polymorphisms of the SOD1 gene are associated with breast cancer risk in a Mexican population.
Gallegos-Arreola MP; Ramírez-Hernández MA; Figuera LE; Zúñiga-González GM; Puebla-Pérez AM
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8017-8027. PubMed ID: 32767328
[TBL] [Abstract][Full Text] [Related]
8. Association of an HLA-G 14-bp Insertion/Deletion polymorphism with high HBV replication in chronic hepatitis.
Laaribi AB; Zidi I; Hannachi N; Ben Yahia H; Chaouch H; Bortolotti D; Zidi N; Letaief A; Yacoub S; Boudabous A; Rizzo R; Boukadida J
J Viral Hepat; 2015 Oct; 22(10):835-41. PubMed ID: 25619305
[TBL] [Abstract][Full Text] [Related]
9. The relationship between functional promoter -94 ins/del ATTG polymorphism in NF-κ B1 gene and the risk of urinary cancer.
Li X; Gao Y; Zhou H; Xu W; Li P; Zhou J; Xu T; Yu B; Xu Z; Zou Q; Yin C; Cai H; Shen W
Cancer Biomark; 2016; 16(1):11-7. PubMed ID: 26484607
[TBL] [Abstract][Full Text] [Related]
10. The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer.
Mohd Suzairi MS; Tan SC; Ahmad Aizat AA; Mohd Aminudin M; Siti Nurfatimah MS; Andee ZD; Ankathil R
Cancer Epidemiol; 2013 Oct; 37(5):634-8. PubMed ID: 23806437
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.
Li T; Huang H; Liao D; Ling H; Su B; Cai M
Mol Genet Genomics; 2015 Aug; 290(4):1235-45. PubMed ID: 25573780
[TBL] [Abstract][Full Text] [Related]
12. PDGFRα promoter polymorphisms and expression patterns influence risk of development of imatinib-induced thrombocytopenia in chronic myeloid leukemia: A study from India.
Guru SA; Mir R; Bhat M; Najar I; Zuberi M; Sumi M; Masroor M; Gupta N; Saxena A
Tumour Biol; 2017 Oct; 39(10):1010428317713857. PubMed ID: 29019285
[TBL] [Abstract][Full Text] [Related]
13. Effect of TP53 16-bp and β-TrCP 9-bp INS/DEL polymorphisms in relation to risk of breast cancer.
Eskandari-Nasab E; Hashemi M; Amininia S; Ebrahimi M; Rezaei M; Hashemi SM
Gene; 2015 Sep; 568(2):181-5. PubMed ID: 26003292
[TBL] [Abstract][Full Text] [Related]
14. The relationship of 50 bp deletion in the promoter region of SOD1 gene with viscosity and trace elements in chronic gastritis with Helicobacter Pylori: A case study.
Duzgun Ergun D; Doganer F; Koc G; Soyocak A; Pastaci Ozsobaci N; Ergun S
J Trace Elem Med Biol; 2022 Sep; 73():127039. PubMed ID: 35868167
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population.
Koc A; Batar B; Celik O; Onaran I; Tasan E; Sultuybek GK
Immunobiology; 2014 Jul; 219(7):531-6. PubMed ID: 24703107
[TBL] [Abstract][Full Text] [Related]
16. A 40-bp insertion/deletion polymorphism of Murine Double Minute2 (MDM2) increased the risk of breast cancer in Zahedan, Southeast Iran.
Hashemi M; Omrani M; Eskandari-Nasab E; Hasani SS; Mashhadi MA; Taheri M
Iran Biomed J; 2014; 18(4):245-9. PubMed ID: 25326024
[TBL] [Abstract][Full Text] [Related]
17. Effect of the 50 bp deletion polymorphism in the SOD1 promoter on SOD1 mRNA levels in Italian ALS patients.
Milani P; Gagliardi S; Bongioanni P; Grieco GS; Dezza M; Bianchi M; Cova E; Ceroni M; Cereda C
J Neurol Sci; 2012 Feb; 313(1-2):75-8. PubMed ID: 22005552
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to preeclampsia is associated with a 50-bp insertion/deletion polymorphism at the promoter region of the
Namdari S; Saadat M
J Turk Ger Gynecol Assoc; 2021 Dec; 22(4):268-272. PubMed ID: 34866367
[TBL] [Abstract][Full Text] [Related]
19. Influence of a 5-bp Indel Polymorphism at Promoter of the GAS5 lncRNA and Risk of Breast Cancer.
Sharifi R; Shahangian SS; Salehi Z; Mashayekhi F; Talesh Sasani S; Mirzanezhad L
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3705-3710. PubMed ID: 33369471
[TBL] [Abstract][Full Text] [Related]
20. Impact of a 50bp insertion/deletion polymorphism of the superoxide dismutase-1 on oxidative stress status and risk of keratoconus.
Sedaghat MR; Shiri H; Tavakkol-Afshari J; Norouzmahani ME; Bahri F; Fooladi S; Momeni-Moghaddam H; Danesh Z; Nikpoor AR; Momeni-Moghaddam MA; Nematollahi MH; Sadeghi J
Exp Eye Res; 2024 Jan; 238():109742. PubMed ID: 38040051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]